Hall Laurie J Trustee Cara Therapeutics, Inc. Transaction History

Hall Laurie J Trustee

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$8.88 - $12.77 $1,243 - $1,787	-140 Reduced 35.9%	250 $3,000
Q3 2022 Oct 11, 2022	SELL	$8.24 - $12.56 $1,565 - $2,386	-190 Reduced 32.76%	390 $4,000
Q1 2022 Apr 06, 2022	BUY	$9.94 - $12.65 $3,379 - $4,301	340 Added 141.67%	580 $7,000
Q3 2021 Oct 04, 2021	SELL	$11.55 - $16.06 $1,732 - $2,409	-150 Reduced 38.46%	240 $4,000
Q3 2020 Oct 09, 2020	BUY	$12.34 - $17.92 $1,480 - $2,150	120 Added 44.44%	390 $5,000
Q4 2019 Feb 12, 2020	BUY	$16.11 - $25.98 $1,933 - $3,117	120 Added 80.0%	270 $4,000
Q3 2019 Oct 25, 2019	BUY	$18.28 - $26.91 $2,742 - $4,036	150 New	150 $3,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.